Farmers & Merchants Investments Inc Biogen Inc. Transaction History

Farmers & Merchants Investments Inc

$2.97 Billion
Q2 2024

A detailed history of Farmers & Merchants Investments Inc transactions in Biogen Inc. stock. As of the latest transaction made, Farmers & Merchants Investments Inc holds 4,007 shares of BIIB stock, worth $783,889. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,007

Previous 4,007 -0.0%

Holding current value

$783,889

Previous $864,000 7.41%

% of portfolio

0.03%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 23, 2024	SELL	$222.59 - $267.94 $4,451 - $5,358	-20 Reduced 0.5%	4,007 $1.04 Million
Q2 2023 Aug 01, 2023	SELL	$275.25 - $318.06 $15,138 - $17,493	-55 Reduced 1.35%	4,027 $1.15 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $3,848 - $4,385	15 Added 0.37%	4,082 $1.13 Million
Q4 2022 Feb 02, 2023	BUY	$252.44 - $306.72 $5,806 - $7,054	23 Added 0.57%	4,067 $1.13 Million
Q3 2022 Oct 31, 2022	SELL	$194.69 - $268.46 $973 - $1,342	-5 Reduced 0.12%	4,044 $1.08 Million
Q2 2022 Jul 28, 2022	BUY	$187.54 - $223.02 $31,694 - $37,690	169 Added 4.36%	4,049 $826,000
Q1 2022 Apr 19, 2022	SELL	$193.77 - $244.14 $23,639 - $29,785	-122 Reduced 3.05%	3,880 $817,000
Q4 2021 Jan 14, 2022	BUY	$223.92 - $287.77 $27,318 - $35,107	122 Added 3.14%	4,002 $960,000
Q3 2021 Oct 21, 2021	SELL	$282.99 - $369.05 $4,810 - $6,273	-17 Reduced 0.44%	3,880 $1.1 Million
Q2 2021 Jul 16, 2021	SELL	$259.0 - $414.71 $272,986 - $437,104	-1,054 Reduced 21.29%	3,897 $1.35 Million
Q1 2021 Apr 14, 2021	SELL	$242.95 - $284.63 $242 - $284	-1 Reduced 0.02%	4,951 $1.39 Million
Q4 2020 Jan 20, 2021	SELL	$236.26 - $355.63 $11,813 - $17,781	-50 Reduced 1.0%	4,952 $1.21 Million
Q3 2020 Oct 19, 2020	SELL	$264.77 - $305.71 $4,501 - $5,197	-17 Reduced 0.34%	5,002 $1.42 Million
Q2 2020 Jul 21, 2020	SELL	$258.66 - $342.55 $490,936 - $650,159	-1,898 Reduced 27.44%	5,019 $1.34 Million
Q1 2020 Apr 16, 2020	SELL	$268.85 - $341.04 $20,701 - $26,260	-77 Reduced 1.1%	6,917 $2.19 Million
Q4 2019 Jan 21, 2020	SELL	$220.06 - $304.07 $101,667 - $140,480	-462 Reduced 6.2%	6,994 $2.08 Million
Q3 2019 Oct 18, 2019	SELL	$217.44 - $243.88 $158,731 - $178,032	-730 Reduced 8.92%	7,456 $1.74 Million
Q2 2019 Jul 24, 2019	SELL	$219.29 - $241.72 $1.46 Million - $1.61 Million	-6,658 Reduced 44.85%	8,186 $1.91 Million
Q1 2019 Apr 26, 2019	SELL	$216.71 - $338.96 $881,359 - $1.38 Million	-4,067 Reduced 21.51%	14,844 $3.51 Million
Q4 2018 Jan 24, 2019	SELL	$278.5 - $352.75 $11,697 - $14,815	-42 Reduced 0.22%	18,911 $5.69 Million
Q3 2018 Oct 30, 2018	SELL	$293.51 - $383.83 $4,109 - $5,373	-14 Reduced 0.07%	18,953 $6.7 Million
Q2 2018 Jul 23, 2018	SELL	$257.52 - $306.91 $15,193 - $18,107	-59 Reduced 0.31%	18,967 $5.51 Million
Q1 2018 Apr 17, 2018	SELL	$260.13 - $367.91 $11,445 - $16,188	-44 Reduced 0.23%	19,026 $5.21 Million
Q4 2017 Jan 26, 2018	BUY	$307.64 - $344.58 $250,111 - $280,143	813 Added 4.45%	19,070 $6.08 Million
Q3 2017 Oct 19, 2017	BUY	$281.15 - $329.69 $5.13 Million - $6.02 Million	18,257	18,257 $5.72 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farmers & Merchants Investments Inc, based on Form 13F filings with the SEC.

News

Stay updated on Farmers & Merchants Investments Inc with notifications on news.

Account

Farmers & Merchants Investments Inc Biogen Inc. Transaction History